Catalent
CTLT
#1587
Rank
โ‚น905.99 B
Marketcap
โ‚น4,991
Share price
-0.17%
Change (1 day)
81.25%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -โ‚น105.61

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น108.86. In 2022 the company made an earnings per share (EPS) of โ‚น191.55 a decrease over its 2021 EPS that were of โ‚น275.94.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น105.61-155.13%
2022โ‚น191.55-30.58%
2021โ‚น275.9479.67%
2020โ‚น153.58114.12%
2019โ‚น71.73-15%
2018โ‚น84.3975.44%
2017โ‚น48.10-22.97%
2016โ‚น62.44-59.56%
2015โ‚น154.42282.05%
2014โ‚น40.42-378.2%
2013-โ‚น14.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น66.66-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น63.29-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น118.98 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น539.22-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA